Proteomic Identification of Plasma Biomarkers in Children and Adolescents with Recurrent Hodgkin Lymphoma

The treatment of paediatric Hodgkin lymphoma (HL) has steadily improved over the years, so that 10- years survival exceed 80%. The purpose of this study was to identify prognostic markers for relapsed HL that might contribute to optimize therapeutic approaches. To this aim we retrospectively analyse...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Cancer
Main Authors: Repetto, Ombretta, Mussolin, Lara, Elia, Caterina, Martina, Lia, Bianchi, Maurizio, Buffardi, Salvatore, Sala, Alessandra, Burnelli, Roberta, Mascarin, Maurizio, De Re, Valli
Formato: Artigo
Idioma:Inglês
Publicado: Ivyspring International Publisher 2018
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6299395/
https://ncbi.nlm.nih.gov/pubmed/30588249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.27560
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares